Literature DB >> 33580536

Unmet social care needs of people living with and beyond cancer: prevalence and predictors from an English longitudinal survey.

Katerina Gousia1,2, Ann-Marie Towers1.   

Abstract

OBJECTIVES: This study estimates the prevalence of unmet social care needs of people over 50 living in England with cancer and the effect of cancer on unmet needs.
METHODS: We used data from the English Longitudinal Study of Ageing. We estimated the mean, standard deviation and 95% CI of the prevalence of unmet social care needs among people with cancer. Logistic regression analysis with individual random effects was used to estimate the effect of cancer on unmet needs controlling for other determinants. Pain measures were included stepwise in the regression to estimate their mediating effect.
RESULTS: The prevalence rate of unmet social care needs among people living with cancer is 9% (SD = 0.29; 95% CI: 8.3-10) compared to 6% (SD = 0.24; 95% CI: 6.1-6.5) among people without cancer. People with cancer have significantly higher odds of having unmet needs by a factor of 1.44 (95% CI: 1.20-1.72), after controlling for the effect of other characteristics. Adding pain measures reduces the effect of cancer to a factor of 1.36 (95% CI: 1.14-1.64) in the odds of unmet needs but still remains statistically significant.
CONCLUSIONS: A more integrated approach to cancer care is more likely to address the high level of unmet needs and consequent adverse implications.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  Psycho-Oncology; cancer; integrated care; longitudinal; pain; person-centred care; social care needs

Year:  2021        PMID: 33580536     DOI: 10.1002/pon.5656

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  1 in total

1.  Integrating Behavioral Health and Serious Illness Care in a Post-COVID-19 Environment.

Authors:  Daniel Shalev; Brigitta Spaeth-Rublee; Stephanie Cheung; Jon A Levenson; Harold Alan Pincus
Journal:  Psychiatr Serv       Date:  2021-06-09       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.